Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling
Top Cited Papers
- 28 January 2026
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 651 (8106) , 829-837
Abstract
Psychedelics are undergoing a renaissance as potential therapy for psychiatric disorders, with more than 200 clinical trials being studied across several countries1,2,3. However, the precise mechanisms by which these drugs bring about benefits and the potential clinical risks are not yet fully understood. The serotonin 2A receptor (5-HT2AR) was reported to be a Gq-coupled receptor and the primary interoceptive target of psychedelics4,5. Here we compared psychedelics and their non-hallucinogenic analogues (nHAs) using in vitro and in vivo approaches, finding that 5-HT2AR-mediated non-canonical Gi signalling is essential for hallucinogenic effect. We further presented five cryo-electron microscopy structures of 5-HT2AR–Gi/Gq in complex with psychedelics or nHAs. Structural analysis and pharmacological investigation revealed that a special contact between nHAs with 5-HT2AR mediated the signalling bias. Building on this insight, we identified a 2,5-dimethoxy-4-iodoamphetamine derivative, DOI-NBOMe, which exhibits potent and selective Gq-biased activity, and demonstrates promising therapeutic effects in mouse models without hallucinogenic effect. Our finding uncovers the functional mechanisms underlying the Gi signalling mediated by 5-HT2AR and provides valuable insights for designing psychedelic-based drugs with minimized risk from hallucinogenic effects.Keywords
This publication has 66 references indexed in Scilit:
- Structural and signaling mechanisms of TAAR1 enabled preferential agonist designCell, 2023
- The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamineBrain, Behavior, and Immunity, 2023
- TRUPATH: An Open-Source Biosensor Platform for Interrogating the GPCR Transducerome2022
- “Selective” serotonin 5-HT2A receptor antagonistsBiochemical Pharmacology, 2022
- Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorCell, 2020
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Psychedelics as Medicines: An Emerging New ParadigmClinical Pharmacology & Therapeutics, 2016
- Distinct Temporal Expression of 5-HT1A and 5-HT2A Receptors on Cerebellar Granule Cells in MiceThe Cerebellum, 2014
- A New Gq-Initiated MAPK Signaling Pathway in the HeartDevelopmental Cell, 2009
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004